Relationship of bradykinin B2 receptor gene polymorphism with essential hypertension and left ventricular hypertrophy

Hypertension Research

Volumn 27, Issue 12, 2004, Pages 933-938

  Fu, Yuxiao ^a   Katsuya, Tomohiro ^a   Matsuo, Akiko ^a   Yamamoto, Koichi ^a   Akasaka, Hiroshi ^a   Takami, Yoichi ^a   Iwashima, Yoshio ^a   Sugimoto, Ken ^a   Ishikawa, Kazuhiko ^a   Ohishi, Mitsuru ^a   Rakugi, Hiromi ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme gene; Bradykinin B2 receptor gene; Hypertension; Left ventricular hypertrophy; TaqMan PCR method

Indexed keywords

BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FEMALE; GEL ELECTROPHORESIS; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INFORMED CONSENT; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PROMOTER REGION; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTOR, BRADYKININ B2;

EID: 20144365634     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.933     Document Type: Article

References (40)

1. Kurtz TW, Spence MA: Genetics of essential hypertension. Am J Med 1993; 94: 77-84.
2. Mullins JJ, Peters J, Ganten D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990; 344: 541-544.
3. Rapp JP, Wang SM, Dene H: A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science 1989; 243: 542-544.
4. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 2: 169-170.
5. Higaki J, Baba S, Katsuya T, et al: Deletion allele of angiotensin-enzyme gene increases risk of essential hypertension in Japanese men: the Suita Study. Circulation 2000; 101: 2060-2065.
6. Katsuya T, Iwashima Y, Sugimoto K, et al: Effects of anti-hypertensive drugs and gene variants in the renin-angiotensin system. Hypertens Res 2002; 24: 463-467.
7. Verdecchia P, Carini G, Crico A, et al: Left ventricular mass and cardiovascular risk in essential hypertension: the MAVI study. J Am Coll Cardiol 2001; 38: 1829-1835.
8. Schunkert H, Hense HW, Hoolmer SR, et al: Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-1638.
9. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M: DD genotype of the angiotensin converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2622-2628.
10. Lindpaintner K, Lee M, Larson MG, et al: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and ventricular mass. N Engl J Med 1996; 334: 1023-1028.
11. Regoli D, Barabc J: Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32: 1-46.
12. Burch RM, Kyle DJ: Minireview: recent development in the understanding of bradykinin receptors. Life Sci 1992; 50: 829-838.
13. Maestri R, Milia AF, Salis MB, et al: Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice. Hypertension 2003; 41: 1151-1155.
14. Braun A, Kammerer S, Maier E, et al: Polymorphism in the gene for the human B2-bradykinin receptor: new tools assessing a genetic risk for bradykinin-associated diseases. Immunopharmacology 1996; 33: 32-35.
15. Kammerer S, Braun A, Arnold N, Roscher AA: The human bradykinin B2 receptor gene: full length cDNA, genomic organization and identification of the regulatory region. Biochem Biophys Res Commun 1995; 211: 226-233.
16. Braun A, Kammerer S, Bohme E, Muller B, Roscher AA: Identification of polymorphic sites of the human bradykinin B2 receptor gene. Biochem Biophys Res Commun 1995; 211: 234-240.
17. Mukae S, Aoki S, Itoh S, et al: Promoter polymorphism of the beta2 bradykinin receptor gene is associated with essential hypertension. Jpn Circ J 1999; 63: 759-762.
18. Gainer JV, Brown NJ, Bachvarova M, et al: Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive Afro-Americans. Am J Hypertens 2000; 13: 1268-1273.
19. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA: Contribution of kinins to the cardiovascular actions of angiotensin-converteing enzyme inhibitors. Pharmacol Rev 1995; 47: 25-49.
20. Hallberg P, Lind L, Michaelsson K, et al: B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. J Hypertens 2003; 21: 621-624.
21. Sugimoto K, Hozawa A, Katsuya K, et al: Alpha-adducin gly460trp polymorphism is associated with low renin hypertension in younger subjects in the Ohasama study. J Hypertens 2002; 20: 1779-1784.
22. Aoki S, Mukae S, Itoh S, et al: The genetic factor in acute myocardial infarction with hypertension. Jpn Circ J 2001; 65: 621-626.
23. Cheng CP, Onishi K, Ohte N, Suzuki M, Little WC: Functional effects of endogenous bradykinin in congestive heart failure. J Am Coll Cardiol 1998; 31: 1679-1686.
24. Emanueli C, Madeddu P: Effect of early blockade of bradykinin B2-receptor on the blood pressure phenotype of normotensive and spontaneously hypertensive rats. Pharmacol Res 1997; 35: 522-526.
25. Kato M, Shiode N, Yamagata T, Matsuura H, Kajiyama G: Coronary segmental responses to acetylcholine and bradykinin in patients with atherosclerotic risk factors. Am J Cardiol 1997; 80: 751-755.
26. Cervenka L, Maly J, Karasova L, et al: Angiotensin II-induced hypertension in bradykini B2 receptor knockout mice. Hypertension 2001; 37: 967-973.
27. Grim CE, Robinson M: Blood pressure variation in blacks: genetic factors. Semin Nephrol 1996; 16: 83-93.
28. Wang B, Dang A, Liu G: Genetic variation in the promoter region of the beta2 bradykinin receptor gene is associated with essential hypertension in a Chinese Han population. Hypertens Res 2001; 24 299-302.
29. Zuraw B: Bradykinin in protection against left-ventricular hypertrophy. Lancet 2001; 358: 1116-1118.
30. Brull D, Dhamrait S, Myerson S, et al: Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet 2001; 358: 1155-1156.
31. Lung CC, Chan EK, Zuraw BL: Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with C1 inhibitor deficiency. J Allergy Clin Immunol 1997; 99: 134-146.
32. AbdAlla S, Lother H, Quitterer U: ATI-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 2000; 407: 94-98.
33. Ohira N, Matsumoto T, Tamaki S, et al: Angiotensin-converting enzyme insertion/deletion polymorphism modulates coronary release of tissue plasminogen activator in response to bradykinin. Hypertens Res 2004; 27: 39-45.
34. Takai S, Jin D, Sakaguchi M, Miyazaki M: Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors. Hypertens Res 2004; 27: 213-219.
35. Schunkert H, Hense HW, Holmer SR, et al: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-1638.
36. Montgomery HE, Clarkson P, Dollery CM, et al: Association of angiotensin-converting-enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997; 96: 741-747.
37. Clarkson PB, Prasad N, MacLeod C, Burchell B, Macdonald TM: Influence of the angiotensin converting enzyme I/D gene polymorphism on left ventricular diastolic filling in patients with essential hypertension. J Hypertens 1997; 15: 995-1000.
38. Danser AH, Schalekamp MA, Bax WA, et al: Angiotensin converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-1388.
39. Myerson S, Montgomery H, Whittingham M, et al: Left ventricular hypertrophy with exercise and the angiotensin converting enzyme I/D gene polymorphism: a randomized controlled trial with losartan. Circulation 2001; 102: 226-230.
40. Murphey LJ, Gainer JV, Vaughan DE, Brown NJ: Angiotensin converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 2000; 102: 829-832.